Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00049972 · ClinicalTrials.gov registry record · Phase 4
Major Depressive Disorder Study In Adults
A Phase 4 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 4
- Development phase
- 646
- Enrollment target
NCT00049972 is a Phase 4 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 646 participants.
The verdict
NCT00049972, a Phase 4 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 646 participants
- Enrollment target
Study Summary
A study to obtain safety and tolerability data
Interventions
- DRUG paroxetine CR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 646 participants |
| Start Date | 2002-09 |
| Est. Completion | 2003-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00049972
The ClinicalTrials.gov registry entry for NCT00049972 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 646 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which paroxetine CR is the first listed.
NCT00049972 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00049972 about?
NCT00049972 is a clinical study titled "Major Depressive Disorder Study In Adults". A study to obtain safety and tolerability data
What is the current status of trial NCT00049972?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 646 participants. The study started on 2002-09. Estimated completion is 2003-09.
What interventions are being tested in trial NCT00049972?
The interventions under investigation include: paroxetine CR (DRUG).
Who is sponsoring clinical trial NCT00049972?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.